tiprankstipranks
Trending News
More News >
Psychemedics (PMDI)
OTHER OTC:PMDI
US Market
Advertisement

Psychemedics (PMDI) Price & Analysis

Compare
118 Followers

PMDI Stock Chart & Stats


PMDI FAQ

What was Psychemedics’s price range in the past 12 months?
Psychemedics lowest stock price was $1.11 and its highest was $3.25 in the past 12 months.
    What is Psychemedics’s market cap?
    Psychemedics’s market cap is $13.14M.
      When is Psychemedics’s upcoming earnings report date?
      Psychemedics’s upcoming earnings report date is Aug 12, 2025 which is 52 days ago.
        How were Psychemedics’s earnings last quarter?
        Currently, no data Available
        Is Psychemedics overvalued?
        According to Wall Street analysts Psychemedics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Psychemedics pay dividends?
          Psychemedics does not currently pay dividends.
          What is Psychemedics’s EPS estimate?
          Psychemedics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Psychemedics have?
          Psychemedics has 6,109,502 shares outstanding.
            What happened to Psychemedics’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Psychemedics?
            Currently, no hedge funds are holding shares in PMDI

            Company Description

            Psychemedics

            Psychemedics Corporation (PMD) is a leader in the field of drug testing, specializing in hair analysis to detect the presence of drugs. The company operates primarily in the healthcare and safety sectors, providing services that cater to a wide range of industries including law enforcement, schools, and employers. Psychemedics is known for its patented hair testing technology, which offers a longer detection window for substance use compared to traditional urine or blood tests.

            Psychemedics (PMDI) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Enzo Biochem
            Prophase Labs
            ModivCare
            Co-Diagnostics
            Mangoceuticals, Inc.

            Ownership Overview

            38.48%0.03%4.52%57.00%
            38.48% Insiders
            4.52% Other Institutional Investors
            57.00% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis